US$ 28.84
how glp 1 drugs work Trends in the Development of GLP-1 Receptor Agonists GLP-1 Therapy Part 1: Setting
Description
Exendin-4 degrades more slowly than the human form of GLP-1, lasting for hours instead of minutes

doi: 10.1155/2021/9923537

doi:10.1111/jcpt.13230 88

doi: 10.1038/nm919 31 SalcedoITweedieDLiYGreigNH

Active cardiovascular events within 90 days of enrolment

Both exenatide and liraglutide are relatively well tolerated, with dose-dependent nausea, vomiting, and diarrhea being the most commonly reported adverse events observed in clinical trials
